Back to Trades
Schoenberg Mark
Chief Medical OfficerCIK 0001763581
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 11
- Companies
- 1
- Active
- 2025–2026
Across 10 filings between 2025–2026, Schoenberg Mark, Chief Medical Officer, has disclosed $1.9M in transactions — all concentrated in UroGen Pharma Ltd. (URGN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jul 10 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $400.0K |
| Jun 24 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $350.1K |
| Jun 9 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $142.6K |
| May 11 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $300.0K |
| Feb 4 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $145.2K |
| Feb 3 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Exercise | $0 |
| Nov 20 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $250.0K |
| Sep 9 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $16.6K |
| Aug 13 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $176.9K |
| Jul 30 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $98.6K |
10 filings